Home » Newsletters » BioWorld MedTech

BioWorld MedTech

April 17, 2012

View Archived Issues

Medtronic reports consistent two-year results for Endurant

No aneurysm-related mortality. No conversion to open surgery. No device migration. Read More

Deals roundup: PHL to acquire imaging research portfolio from Bayer Pharma

Report from Europe: Cross-border e-health goes live in Europe

Agreements/contracts: NeuroLogica's BodyTom to integrate Brainlab system

Financings roundup: Molecular Detection closes $1.9M Series B financing

Med-Tech Notes: Iowa Methodist uses a BSD-500

Patent watch: Vermillion receives 15th patent related to OVA1 diagnostic test

Product Briefs

People in the News

MDD's Cardio Extra

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...